Positive CHMP Opinion
CHMP recommends EU approval for Duvyzat to treat Duchenne muscular dystrophy
Sorodne novice
EU Approves Duvyzat for the Treatment of Duchenne Muscular Dystrophy
Italfarmaco is now working closely with national authorities and distribution partners to facilitate timely access to Duvyzat across the EU.
Preberi več
Italfarmaco and Medis Announce Exclusive Distribution Agreement for Givinostat in 17 Central and Eastern European Countries including the Baltic States
Givinostat has already received regulatory approval in the US and UK, with an evaluation ongoing by the European Medicines Agency (EMA).
Preberi več